OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Brain-first vs. body-first Parkinson's disease: An update on recent evidence
Jacob Horsager, Per Borghammer
Parkinsonism & Related Disorders (2024) Vol. 122, pp. 106101-106101
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Clinically probable RBD is an early predictor of malignant non-motor Parkinson’s disease phenotypes
Alfonso Enrique Martinez-Nunez, Hunter Hutchinson, Patricia Coutinho, et al.
npj Parkinson s Disease (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1

Lewy body diseases and the gut
Timothy R. Sampson, Malú G. Tansey, Andrew B. West, et al.
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1

Integrating digital gait data with metabolomics and clinical data to predict outcomes in Parkinson’s disease
Cyril Brzenczek, Quentin Klopfenstein, Tom Hähnel, et al.
npj Digital Medicine (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 6

Microbiota–neuroepithelial signalling across the gut–brain axis
Takahiro E. Ohara, Elaine Y. Hsiao
Nature Reviews Microbiology (2025)
Closed Access

Managing sleep issues in Parkinson’s disease: an up-to-date review
Keisuke Suzuki, Hiroaki Fujita, Saro Kobayashi
Expert Review of Neurotherapeutics (2025), pp. 1-16
Open Access

Amygdala neurodegeneration differentiates brain-first and body-first Parkinson's disease: An MRI study
Nils Schröter, Laura Matinpalo, Jonas A. Hosp, et al.
Parkinsonism & Related Disorders (2025) Vol. 135, pp. 107827-107827
Open Access

Pathophysiological Significance of α-Synuclein in Sympathetic Nerves
Risa Isonaka, Patti Sullivan, David S. Goldstein
Neurology (2025) Vol. 104, Iss. 3
Closed Access

Impulse control disorders in Parkinson’s disease: What’s new?
Ana Marqués, Simon J.G. Lewis
Journal of Neurology (2025) Vol. 272, Iss. 2
Closed Access

Non-motor Symptoms and Treatments in Parkinson’s Disease
Jennifer G. Goldman
Neurologic Clinics (2025) Vol. 43, Iss. 2, pp. 291-317
Closed Access

Potential Risk Factors for Psychosis in Parkinson’s Disease: A Review of Cohort and Case-Control Studies
Dimitry S. Davydow, Michael S. Okun, Gregory M. Pontone
Journal of Geriatric Psychiatry and Neurology (2025)
Closed Access

Advances in autonomic dysfunction research in Parkinson’s disease
Huichun Xu, Xiaolei Zheng, Xinyue Xing, et al.
Frontiers in Aging Neuroscience (2025) Vol. 17
Open Access

The Gut‐Brain Axis in Parkinson disease: Emerging Concepts and Therapeutic Implications
Elisa Menozzi, Anthony H.V. Schapira, Per Borghammer
Movement Disorders Clinical Practice (2025)
Open Access

The natural history of body-first versus brain-first Parkinson’s disease subtypes
Vittorio Velucci, Angelo Fabio Gigante, Giovanni Iliceto, et al.
Journal of Neurology (2025) Vol. 272, Iss. 5
Open Access

Exploring glymphatic system alterations in iRBD and Parkinson’s disease using automated DTI-ALPS analysis
Stanislav Mareček, Veronika Rottova, Jiří Nepožitek, et al.
npj Parkinson s Disease (2025) Vol. 11, Iss. 1
Open Access

A Population‐Based Approach to the Argument on Brain‐First and Body‐First Pathogenesis of Lewy Body Disease
Emanuele Camerucci, Aidan F. Mullan, Pierpaolo Turcano, et al.
Annals of Neurology (2024) Vol. 96, Iss. 3, pp. 551-559
Closed Access | Times Cited: 3

Modulating the biosynthesis and TLR4-interaction of lipopolysaccharide as an approach to counter gut dysbiosis and Parkinson’s disease: role of phyto-compounds
Rubina Roy, Diwakar Kumar, Pallab Bhattacharya, et al.
Neurochemistry International (2024) Vol. 178, pp. 105803-105803
Closed Access | Times Cited: 2

Microbiome-based therapeutics for Parkinson's disease
Adam M. Hamilton, Ian N Krout, Alexandria C. White, et al.
Neurotherapeutics (2024) Vol. 21, Iss. 6, pp. e00462-e00462
Closed Access | Times Cited: 2

Neuroimaging meta-analyses reveal convergence of interoception, emotion, and social cognition across neurodegenerative diseases.
Jessica L. Hazelton, Fábio Carneiro, Marcelo Maito, et al.
Biological Psychiatry (2024)
Closed Access | Times Cited: 2

Fecal Microbiome Transplants For Parkinson Disease
Timothy R. Sampson
JAMA Neurology (2024) Vol. 81, Iss. 9, pp. 911-911
Closed Access | Times Cited: 1

Metagenomic Analysis Reveals Large‐Scale Disruptions of the Gut Microbiome in Parkinson's Disease
Avril Metcalfe‐Roach, Mihai Cirstea, Adam C. Yu, et al.
Movement Disorders (2024) Vol. 39, Iss. 10, pp. 1740-1751
Open Access | Times Cited: 1

Cortical Functional Connectivity Changes in the Body‐First and Brain‐First Subtypes of Parkinson's Disease
Matteo Conti, Valentina D’Onofrio, Roberta Bovenzi, et al.
Movement Disorders (2024)
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top